Gene variation boosts heart disease risk from chemo

05/21/2010 | HealthDay News

Children with CBR gene variations who are given anthracycline chemotherapy for cancer have a higher risk of developing heart disease later in life, a study found. Researchers said the data could one day help doctors screen children for the variation and offer alternative therapies that don't damage the heart.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA